Pantoprazole Sodium for Injection
Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass
Recalls of acid reducers and stomach drugs - the class behind the ranitidine (Zantac) nitrosamine recalls.
211 recalls in this category, newest first.
Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass
Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval.
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Failed Tablet/Capsule Specification; out of specification for tablet weight
CGMP Deviations
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.
Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Microbial Contamination of Non-Sterile Product
Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
CGMP Deviations
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications; 12 month stability time point
Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.
Lack of Assurance of Sterility
Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Stability data does not support expiry.
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Lack of Assurance of Sterility: Sterility of product is not assured.
Lack of Assurance of Sterility: Sterility of product is not assured.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.